Literature DB >> 28273720

Recurrence of glioblastoma is associated with elevated microvascular transit time heterogeneity and increased hypoxia.

Andreas Stadlbauer1,2, Kim Mouridsen3, Arnd Doerfler4, Mikkel Bo Hansen3, Stefan Oberndorfer5, Max Zimmermann1, Michael Buchfelder1, Gertraud Heinz2, Karl Roessler1.   

Abstract

Dynamic susceptibility contrast (DSC) perfusion MRI provide information about differences in macro- and microvasculature when executed with gradient-echo (GE; sensitive to macrovasculature) and spin-echo (SE; sensitive to microvasculature) contrast. This study investigated whether there are differences between macro- and microvascular transit time heterogeneity (MVTH and µVTH) and tissue oxygen tension (PO2mit) in newly-diagnosed and recurrent glioblastoma. Fifty-seven patients with glioblastoma (25 newly-diagnosed/32 recurrent) were examined with GE- and SE-DSC perfusion sequences, and a quantitative blood-oxygen-level-dependent (qBOLD) approach. Maps of MVTH, µVTH and coefficient of variation (MCOV and µCOV) were calculated from GE- and SE-DSC data, respectively, using an extended flow-diffusion equation. PO2mit maps were calculated from qBOLD data. Newly-diagnosed and recurrent glioblastoma showed significantly lower ( P ≤ 0.001) µCOV values compared to both normal brain and macrovasculature (MCOV) of the lesions. Recurrent glioblastoma had significantly higher µVTH ( P = 0.014) and µCOV ( P = 0.039) as well as significantly lower PO2mit values ( P = 0.008) compared to newly-diagnosed glioblastoma. The macrovasculature, however, showed no significant differences. Our findings provide evidence of microvascular adaption in the disorganized tumor vasculature for retaining the metabolic demands in stress response of therapeutically-uncontrolled glioblastomas. Thus, µVTH and PO2mit mapping gives insight into the tumor microenvironment (vascular and hypoxic niches) responsible for therapy resistance.

Entities:  

Keywords:  Glioblastoma; microvasculature; oxygen-tension; recurrence; transit-time-heterogeneity

Mesh:

Substances:

Year:  2017        PMID: 28273720      PMCID: PMC5851132          DOI: 10.1177/0271678X17694905

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  50 in total

1.  Perfusion MRI of the human brain with dynamic susceptibility contrast: gradient-echo versus spin-echo techniques.

Authors:  O Speck; L Chang; N M DeSilva; T Ernst
Journal:  J Magn Reson Imaging       Date:  2000-09       Impact factor: 4.813

2.  The effects of transit time heterogeneity on brain oxygenation during rest and functional activation.

Authors:  Peter M Rasmussen; Sune N Jespersen; Leif Østergaard
Journal:  J Cereb Blood Flow Metab       Date:  2014-12-10       Impact factor: 6.200

3.  Combined spin- and gradient-echo perfusion-weighted imaging.

Authors:  Heiko Schmiedeskamp; Matus Straka; Rexford D Newbould; Greg Zaharchuk; Jalal B Andre; Jean-Marc Olivot; Michael E Moseley; Gregory W Albers; Roland Bammer
Journal:  Magn Reson Med       Date:  2011-11-23       Impact factor: 4.668

4.  Reliable estimation of microvascular flow patterns in patients with disrupted blood-brain barrier using dynamic susceptibility contrast MRI.

Authors:  Mikkel Bo Hansen; Anna Tietze; Jayashree Kalpathy-Cramer; Elizabeth R Gerstner; Tracy T Batchelor; Leif Østergaard; Kim Mouridsen
Journal:  J Magn Reson Imaging       Date:  2016-11-30       Impact factor: 4.813

5.  Assessment of tumor oxygenation and its impact on treatment response in bevacizumab-treated recurrent glioblastoma.

Authors:  David Bonekamp; Kim Mouridsen; Alexander Radbruch; Felix T Kurz; Oliver Eidel; Antje Wick; Heinz-Peter Schlemmer; Wolfgang Wick; Martin Bendszus; Leif Østergaard; Philipp Kickingereder
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-21       Impact factor: 6.200

6.  Slice accelerated gradient-echo spin-echo dynamic susceptibility contrast imaging with blipped CAIPI for increased slice coverage.

Authors:  Cornelius Eichner; Kourosh Jafari-Khouzani; Stephen Cauley; Himanshu Bhat; Pavlina Polaskova; Ovidiu C Andronesi; Otto Rapalino; Robert Turner; Lawrence L Wald; Steven Stufflebeam; Kawin Setsompop
Journal:  Magn Reson Med       Date:  2013-10-28       Impact factor: 4.668

7.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

8.  The relationship between tumor blood flow, angiogenesis, tumor hypoxia, and aerobic glycolysis.

Authors:  Leif Ostergaard; Anna Tietze; Thomas Nielsen; Kim Ryun Drasbek; Kim Mouridsen; Sune Nørhøj Jespersen; Michael R Horsman
Journal:  Cancer Res       Date:  2013-06-13       Impact factor: 12.701

Review 9.  Detection and characterization of tumor hypoxia using pO2 histography.

Authors:  Peter Vaupel; Michael Höckel; Arnulf Mayer
Journal:  Antioxid Redox Signal       Date:  2007-08       Impact factor: 8.401

10.  The roles of cerebral blood flow, capillary transit time heterogeneity, and oxygen tension in brain oxygenation and metabolism.

Authors:  Sune N Jespersen; Leif Østergaard
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-02       Impact factor: 6.200

View more
  15 in total

1.  Development of a Non-invasive Assessment of Hypoxia and Neovascularization with Magnetic Resonance Imaging in Benign and Malignant Breast Tumors: Initial Results.

Authors:  Andreas Stadlbauer; Max Zimmermann; Barbara Bennani-Baiti; Thomas H Helbich; Pascal Baltzer; Paola Clauser; Panagiotis Kapetas; Zsuzsanna Bago-Horvath; Katja Pinker
Journal:  Mol Imaging Biol       Date:  2019-08       Impact factor: 3.488

2.  Association between tissue hypoxia, perfusion restrictions, and microvascular architecture alterations with lesion-induced impairment of neurovascular coupling.

Authors:  Andreas Stadlbauer; Thomas M Kinfe; Max Zimmermann; Ilker Eyüpoglu; Nadja Brandner; Michael Buchfelder; Moritz Zaiss; Arnd Dörfler; Sebastian Brandner
Journal:  J Cereb Blood Flow Metab       Date:  2020-08-12       Impact factor: 6.200

Review 3.  Cerebral oxygen extraction fraction MRI: Techniques and applications.

Authors:  Dengrong Jiang; Hanzhang Lu
Journal:  Magn Reson Med       Date:  2022-05-05       Impact factor: 3.737

4.  Intratumoral heterogeneity of oxygen metabolism and neovascularization uncovers 2 survival-relevant subgroups of IDH1 wild-type glioblastoma.

Authors:  Andreas Stadlbauer; Max Zimmermann; Arnd Doerfler; Stefan Oberndorfer; Michael Buchfelder; Roland Coras; Melitta Kitzwögerer; Karl Roessler
Journal:  Neuro Oncol       Date:  2018-10-09       Impact factor: 12.300

5.  Vascular Hysteresis Loops and Vascular Architecture Mapping in Patients with Glioblastoma treated with Antiangiogenic Therapy.

Authors:  Andreas Stadlbauer; Max Zimmermann; Stefan Oberndorfer; Arnd Doerfler; Michael Buchfelder; Gertraud Heinz; Karl Roessler
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

Review 6.  Advancements in Neuroimaging to Unravel Biological and Molecular Features of Brain Tumors.

Authors:  Francesco Sanvito; Antonella Castellano; Andrea Falini
Journal:  Cancers (Basel)       Date:  2021-01-23       Impact factor: 6.639

7.  Imaging effective oxygen diffusivity in the human brain with multiparametric magnetic resonance imaging.

Authors:  Jan Kufer; Christine Preibisch; Samira Epp; Jens Göttler; Lena Schmitzer; Claus Zimmer; Fahmeed Hyder; Stephan Kaczmarz
Journal:  J Cereb Blood Flow Metab       Date:  2021-09-30       Impact factor: 6.200

8.  Gene Suppression of Transketolase-Like Protein 1 (TKTL1) Sensitizes Glioma Cells to Hypoxia and Ionizing Radiation.

Authors:  Sonja Heller; Gabriele D Maurer; Christina Wanka; Ute Hofmann; Anna-Luisa Luger; Ines Bruns; Joachim P Steinbach; Johannes Rieger
Journal:  Int J Mol Sci       Date:  2018-07-25       Impact factor: 5.923

9.  Evaluation of a tumor electric field treatment system in a rat model of glioma.

Authors:  Hao Wu; Chenxi Wang; Jialin Liu; Dan Zhou; Dikang Chen; Zhixiong Liu; Anhua Wu; Lin Yang; Jiusheng Chang; Chengke Luo; Wen Cheng; Shuai Shen; Yunjuan Bai; Xuetao Mu; Chong Li; Zhifei Wang; Ling Chen
Journal:  CNS Neurosci Ther       Date:  2020-07-30       Impact factor: 5.243

10.  Physiological MRI of microvascular architecture, neovascularization activity, and oxygen metabolism facilitate early recurrence detection in patients with IDH-mutant WHO grade 3 glioma.

Authors:  Andreas Stadlbauer; Gertraud Heinz; Stefan Oberndorfer; Max Zimmermann; Thomas M Kinfe; Michael Buchfelder; Arnd Dörfler; Natalia Kremenevski; Franz Marhold
Journal:  Neuroradiology       Date:  2021-06-11       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.